Shima, K. R., Ota, T., Kato, K., Takeshita, Y., Misu, H., Kaneko, S., & Takamura, T. (2018). Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: A pilot randomized controlled and add-on study. BMJ Open Diabetes Res Care.

Shima, Kosuke Robert, Tsuguhito Ota, Ken-ichiro Kato, Yumie Takeshita, Hirofumi Misu, Shuichi Kaneko, and Toshinari Takamura. "Ursodeoxycholic Acid Potentiates Dipeptidyl Peptidase-4 Inhibitor Sitagliptin By Enhancing Glucagon-like Peptide-1 Secretion in Patients With Type 2 Diabetes and Chronic Liver Disease: A Pilot Randomized Controlled and Add-on Study." BMJ Open Diabetes Res Care 2018.

Shima, Kosuke Robert, et al. "Ursodeoxycholic Acid Potentiates Dipeptidyl Peptidase-4 Inhibitor Sitagliptin By Enhancing Glucagon-like Peptide-1 Secretion in Patients With Type 2 Diabetes and Chronic Liver Disease: A Pilot Randomized Controlled and Add-on Study." BMJ Open Diabetes Res Care 2018.